Angioplasty.Org | Boston Scientific Receives FDA Approval For Promus PREMIER™ Everolimus ... Angioplasty.Org November 25, 2013 -- Natick, Massachusetts -- Continuing to advance leading drug-eluting stent (DES) technology, Boston Scientific Corporation (NYSE: BSX) has received U.S. Food and Drug Administration (FDA) approval for the Promus PREMIER™ ... |
